Very interestingly, in both ALS and SMA patients, CRABP1 expression is significantly reduced (dropped to 0.12 and 0.01 fold, respectively, as compared to healthy levels) (Figure 5a). The gene discussed is CRABP1; the disease is amyotrophic lateral sclerosis.